7Baggers
 Krystal Biotech Hits Day High with 9.54% Surge in Strong Performance  Markets Mojo Fri, 03 Oct 2025 08:30:27 GMT
 Exploring 3 High Growth Tech Stocks in the US Market  simplywall.st Thu, 02 Oct 2025 11:15:00 GMT
 krystal biotech hits day high with 9.54% surge in strong performance  Markets Mojo Wed, 01 Oct 2025 17:52:02 GMT
 Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?  Zacks Investment Research Tue, 30 Sep 2025 13:32:49 GMT
 local biotech co-founder named to forbes 50 over 50  MSN Tue, 23 Sep 2025 13:32:03 GMT
 krystal biotech, inc. $krys shares sold by atle fund management ab  MarketBeat Sun, 21 Sep 2025 11:03:40 GMT
 strs ohio invests $1.24 million in krystal biotech, inc. $krys  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 Krystal Biotech (NASDAQ:KRYS) Trading 7.5% Higher - What's Next?  MarketBeat Sat, 20 Sep 2025 07:00:00 GMT
 strs ohio buys new position in krystal biotech, inc. $krys  MarketBeat Sat, 20 Sep 2025 02:26:15 GMT
 Krystal Biotech (NASDAQ:KRYS) Earns Buy Rating from HC Wainwright  MarketBeat Fri, 19 Sep 2025 07:00:00 GMT
 strs ohio invests $1.24 million in krystal biotech, inc. $krys  MarketBeat Thu, 18 Sep 2025 07:18:41 GMT
 krystal biotech (nasdaq:krys) trading up 7.5% - here's why  MarketBeat Thu, 18 Sep 2025 02:20:15 GMT
 krystal biotech hits day high with 8.37% surge in stock price  Markets Mojo Wed, 17 Sep 2025 20:39:21 GMT
 krystal biotech gets expanded fda approval for vyjuvek  MSN Tue, 16 Sep 2025 17:42:04 GMT
 Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update  Yahoo Finance Tue, 16 Sep 2025 07:00:00 GMT
 Krystal Biotech stock receives Buy rating as FDA expands VYJUVEK label  Investing.com Tue, 16 Sep 2025 07:00:00 GMT
 3 promising growth companies with insider ownership up to 18%  simplywall.st Tue, 16 Sep 2025 07:00:00 GMT
 krystal biotech announces fda approval of update vyjuvek label  TipRanks Tue, 16 Sep 2025 00:19:51 GMT
 Krystal Biotech stock jumps after FDA expands VYJUVEK label  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 Krystal Biotech gets expanded FDA approval for Vyjuvek (KRYS:NASDAQ)  Seeking Alpha Mon, 15 Sep 2025 07:00:00 GMT
 FDA approves expanded label for Krystal Biotech’s DEB treatment  Investing.com Mon, 15 Sep 2025 07:00:00 GMT
 Krystal Biotech Shares Surge on FDA Approval News  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 krystal biotech announces fda approval of updated vyjuvek label  MarketScreener Mon, 15 Sep 2025 07:00:00 GMT
 william blair maintains krystal biotech(krys.us) with buy rating  富途牛牛 Mon, 15 Sep 2025 07:00:00 GMT
 krystal biotech announces fda approval of update vyjuvek label  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 5 best stocks to buy for september 2025  Forbes Thu, 11 Sep 2025 10:00:00 GMT
 best stocks to buy now for september 2025  Forbes Thu, 11 Sep 2025 10:00:00 GMT
 brokerages set krystal biotech, inc. (nasdaq:krys) pt at $210.38  MarketBeat Tue, 09 Sep 2025 08:31:03 GMT
 braidwell lp raises stake in krystal biotech, inc. $krys  MarketBeat Sat, 06 Sep 2025 07:00:00 GMT
 jump financial llc invests $538,000 in krystal biotech, inc. $krys  MarketBeat Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 08:33:01  Newser Thu, 04 Sep 2025 13:33:01 GMT
 halted trials, patient deaths, and more: recent news on oncology research concerns  Oncology News Central Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 01:04:58  Newser Thu, 04 Sep 2025 06:04:58 GMT
 krystal biotech navigates investor confidence amid mixed signals  AD HOC NEWS Thu, 04 Sep 2025 04:27:04 GMT
 high growth tech stocks in us for september 2025  simplywall.st Wed, 03 Sep 2025 11:15:59 GMT
 krystal biotech to present at cantor global healthcare conference 2025  The Manila Times Tue, 02 Sep 2025 12:09:06 GMT
 published on: 2025-09-02 02:18:02  Newser Tue, 02 Sep 2025 07:18:02 GMT
 published on: 2025-08-31 03:58:45  Newser Sun, 31 Aug 2025 08:58:45 GMT

Krystal Biotech, Inc
(NASDAQ:KRYS) 

KRYS stock logo

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullo...

Founded: 2015
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends